Exacerbation of apoptosis of cortical neurons following traumatic brain injury in par-4 transgenic mice.
Traumatic brain injury (TBI) is a significant clinical problem, yet few effective strategies for treating it have emerged. People that sustain and survive a TBI are left with significant cognitive, behavioral, and communicative disabilities. Apoptotic neuronal death occurs following TBI. Prostate apoptosis response-4 (Par-4) is a death domain-containing protein initially characterized as a critical regulator of apoptosis in prostate cancer cells. We have recently generated and characterized Par-4 transgenic mice in which the expression of the par-4 transgene was limited to cells of neuronal lineage. We now provide evidence that, in cortical neurons from these mice, Par-4 drastically increases apoptotic neuronal death in both in vitro and in vivo models of TBI. In vitro experiments were performed in 7-day-old primary cultures of cortical neurons using a previously published, scratch-induced mechanical trauma model. Neurons that overexpress Par-4 showed not only a significant decrease in overall neuron survival after TBI compared to wild-type cells, but also exhibited a sharper decrease in mitochondrial transmembrane potential, a higher degree of free radical accumulation, and earlier activation of caspase-3 than wild-type cells did. In vivo experiments were performed utilizing a weight drop TBI model. A significantly increased volume of cortical injury and exacerbated activation of caspase-3 were observed in Par-4 transgenic mice when compared to those in wild-type mice. These data suggests that aberrant Par-4 expression exacerbates neuronal cell death following TBI by altering mitochondrial function, enhancing oxidative damage, and execution of apoptosis via caspase activation.
Payette
Daniel J
DJ
Department of Physiology, The University of Oklahoma Health Sciences Center Oklahoma City, OK, USA.
Xie
Jun
J
Shirwany
Najeeb
N
Guo
Qing
Q
Annu Rev Pharmacol Toxicol. 2007;47:117-41
16879082
J Neurotrauma. 2006 Aug;23(8):1241-53
16928182
J Biol Chem. 2004 Feb 6;279(6):4596-603
14627703
J Microsc. 1988 May;150(Pt 2):117-36
3411604
J Neurochem. 2000 Jul;75(1):117-24
10854254
Int J Dev Neurosci. 2004 Nov;22(7):485-96
15465278
Apoptosis. 1998 Mar;3(2):61-6
14646502
J Neurotrauma. 2000 Oct;17(10):927-38
11063058
J Neurotrauma. 2002 Apr;19(4):427-38
11990349
Clin Exp Pharmacol Physiol. 2001 Nov;28(11):919-21
11703396
Exp Cell Res. 2003 Feb 1;283(1):51-66
12565819
J Cereb Blood Flow Metab. 2001 Oct;21(10):1189-98
11598496
J Biol Chem. 2004 Jul 2;279(27):28266-75
15090548
J Neurochem. 2005 Jan;92(1):59-71
15606896
J Biol Chem. 2003 May 30;278(22):19995-20005
12644474
J Endocrinol. 2007 Jul;194(1):77-85
17592023
J Biol Chem. 2001 Mar 9;276(10):7320-6
11058599
Biochem J. 1999 Jul 15;341 ( Pt 2):233-49
10393078
J Neurosci Res. 2005 Jan 1-15;79(1-2):231-9
15573402
Cell Death Differ. 1999 Nov;6(11):1067-74
10578175
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4125-30
10097174
Brain Res. 2001 Oct 5;915(1):1-10
11578614
Neuron. 1989 Jun;2(6):1541-5
2576374
Exp Neurol. 2001 Jul;170(1):140-8
11421591
Neurosci Behav Physiol. 2002 Sep-Oct;32(5):541-7
12403008
J Neurosci. 2006 Nov 8;26(45):11540-53
17093075
Nat Med. 1998 Aug;4(8):957-62
9701251
J Mol Neurosci. 1999 Aug-Oct;13(1-2):17-30
10691289
Anat Rec. 1998 Jun;253(3):79-90
9700393
Int J Legal Med. 2007 Sep;121(5):365-75
17106737
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4397-401
7753817
Exp Neurol. 1994 Dec;130(2):173-7
7867748
J Am Soc Nephrol. 2006 Dec;17(12):3336-46
17065240
J Neurochem. 1999 Mar;72(3):1019-29
10037473
Neurocrit Care. 2005;3(2):177-82
16174891
CNS Drugs. 2001;15(7):553-81
11510625
Neurobiol Dis. 2004 Jun;16(1):150-7
15207272
J Neurosci Res. 2007 Mar;85(4):805-15
17243171
J Neurosci. 1999 Aug 1;19(15):6248-56
10414954
Brain Pathol. 2004 Apr;14(2):215-22
15193035
Heart Lung Circ. 2006 Apr;15(2):124-9
16490400
Cell Death Differ. 1998 Dec;5(12):1004-16
9894607
J Comp Neurol. 1999 Aug 30;411(3):390-8
10413774
Am J Physiol Renal Physiol. 2007 Jan;292(1):F107-15
16896190
Annu Rev Neurosci. 2000;23:73-87
10845059
Oncogene. 1999 Jan 21;18(3):623-31
9989812
Mol Cell Biol. 1997 Jul;17(7):3823-32
9199316
Genes Dev. 1999 Aug 1;13(15):1899-911
10444588
Mol Cell Biol. 2003 Aug;23(16):5516-25
12897127